A detailed history of Cim Investment Management Inc transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Cim Investment Management Inc holds 15,963 shares of FOLD stock, worth $175,273. This represents 0.05% of its overall portfolio holdings.

Number of Shares
15,963
Previous 19,762 19.22%
Holding current value
$175,273
Previous $232,000 31.9%
% of portfolio
0.05%
Previous 0.07%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$9.04 - $11.75 $34,342 - $44,638
-3,799 Reduced 19.22%
15,963 $158,000
Q1 2023

May 16, 2023

BUY
$10.91 - $13.54 $7,418 - $9,207
680 Added 3.56%
19,762 $219,000
Q1 2022

May 17, 2022

SELL
$7.89 - $12.48 $17,531 - $27,730
-2,222 Reduced 10.43%
19,082 $181,000
Q4 2021

May 19, 2022

SELL
$9.82 - $12.44 $209,205 - $265,021
-21,304 Reduced 50.0%
21,304 $246,000
Q4 2021

Feb 02, 2022

BUY
$9.82 - $12.44 $209,205 - $265,021
21,304 Added 100.0%
42,608 $449,000
Q1 2021

May 20, 2021

BUY
$9.2 - $23.86 $106,416 - $275,988
11,567 Added 118.79%
21,304 $210,000
Q4 2020

Feb 17, 2021

SELL
$13.47 - $24.89 $131,224 - $242,478
-9,742 Reduced 50.01%
9,737 $225,000
Q3 2020

Nov 16, 2020

BUY
$12.89 - $15.89 $3,622 - $4,465
281 Added 1.46%
19,479 $275,000
Q2 2020

Aug 14, 2020

SELL
$8.86 - $15.69 $18,109 - $32,070
-2,044 Reduced 9.62%
19,198 $290,000
Q1 2020

May 22, 2020

SELL
$6.63 - $11.16 $132,600 - $223,200
-20,000 Reduced 48.49%
21,242 $196,000
Q4 2019

Feb 14, 2020

BUY
$7.48 - $10.75 $308,490 - $443,351
41,242 New
41,242 $402,000

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $3.08B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Cim Investment Management Inc Portfolio

Follow Cim Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cim Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cim Investment Management Inc with notifications on news.